Weight loss with GLP-1 therapy follows a predictable trajectory, though individual results vary based on starting point, consistency, and lifestyle factors
For patients already exploring non-injectable options, the oral semaglutide drops guide covers currently available alternatives
Beneficiaries with Part D benefits can qualify for discounted GLP-1 coverage by meeting one of the following requirements: Group 1 : Overweight individuals with a Body Mass Index (BMI) greater than 27, individuals with prediabetes or have had a heart attack, stroke or blocked arteries in your legs or arms Group 2 : Overweight individuals with a BMI greater than 30, individuals with certain types of heart failure, high blood pressure thats hard to control, or chronic kidney disease (stage 3a or above) Group 3 : Overweight individuals with a BMI greater than 35
Dont put the base cap back on, as doing so could damage the needle
Progress is not linear honor the days when your body needs rest